(Q33830604)

29 July 2017

title

A novel monoclonal antibody specific for canine CD25 (P4A10): selection and evaluation of canine Tregs (English)

1 reference

29 July 2017

1 reference

V Kraig Abrams

1

1 reference

29 July 2017

Billanna Hwang

2

1 reference

29 July 2017

Marina Lesnikova

3

1 reference

29 July 2017

M John Gass

4

1 reference

29 July 2017

Elizabeth Wayner

5

1 reference

29 July 2017

Cristina Castilla-Llorente

6

1 reference

29 July 2017

George E Georges

7

1 reference

29 July 2017

Richard A Nash

8

1 reference

29 July 2017

language of work or name

1 reference

29 December 2009

1 reference

Veterinary Immunology and Immunopathology

29 July 2017

published in

1 reference

29 July 2017

volume

135

1 reference

29 July 2017

issue

3-4

1 reference

29 July 2017

page(s)

257-265

1 reference

Immunomodulatory effects of mixed hematopoietic chimerism: immune tolerance in canine model of lung transplantation

29 July 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2864801

Regulatory T cells are reduced during anti-CD25 antibody treatment of multiple sclerosis.

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2864801

High-dose humanized anti-IL-2 receptor alpha antibody (daclizumab) for the treatment of active, non-infectious uveitis

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2864801

Is FOXP3 a bona fide marker for human regulatory T cells?

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2864801

Cloning of feline FOXP3 and detection of expression in CD4+CD25+ regulatory T cells

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2864801

Serum soluble interleukin 2 receptor alpha in human cancer of adults and children: a review

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2864801

Daclizumab phase II trial in relapsing and remitting multiple sclerosis: MRI and clinical results

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2864801

Development of monoclonal antibodies to integrin receptors

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2864801

RA8, a human anti-CD25 antibody against human Treg cells

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2864801

Daclizumab (anti-Tac, Zenapax) in the treatment of leukemia/lymphoma

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2864801

Expansion of CD4+CD25+ suppressive regulatory T cells from rhesus macaque peripheral blood by FN18/antihuman CD28-coated Dynal beads

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2864801

Daclizumab, a humanised monoclonal antibody to the interleukin 2 receptor (CD25), for the treatment of moderately to severely active ulcerative colitis: a randomised, double blind, placebo controlled, dose ranging trial

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2864801

Tr1 cells: from discovery to their clinical application.

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2864801

De novo generation of antigen-specific CD4+CD25+ regulatory T cells from human CD4+CD25- cells

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2864801

Humanized anti-CD25 (daclizumab) inhibits disease activity in multiple sclerosis patients failing to respond to interferon beta

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2864801

Induction of FoxP3 and acquisition of T regulatory activity by stimulated human CD4+CD25– T cells

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2864801

Control of regulatory T cell development by the transcription factor Foxp3

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2864801

Advances in interleukin 2 receptor targeted treatment

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2864801

Randomised trial of basiliximab versus placebo for control of acute cellular rejection in renal allograft recipients. CHIB 201 International Study Group

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2864801

Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2864801

Monoclonal antibodies in human organ transplantation and auto-immune diseases

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2864801

The antibody against human CD25, ACT-1, recognizes canine T-lymphocytes in the G2/M and G0/G1 phases of the cell cycle during proliferation

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2864801

Identification and monitoring of effector and regulatory T cells during experimental arthritis based on differential expression of CD25 and CD134.

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2864801

Use of FoxP3 expression to identify regulatory T cells in healthy dogs and dogs with cancer

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2864801

Quantification of mRNA encoding cytokines and chemokines in nasal biopsies from dogs with sino-nasal aspergillosis

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2864801

Selective expression of integrin alpha 4 beta 7 on a subset of human CD4+ memory T cells with Hallmarks of gut-trophism.

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2864801

Daclizumab improves asthma control in patients with moderate to severe persistent asthma: a randomized, controlled trial

29 October 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2009.12.006

Reactivity of antibodies directed against human antigens with surface markers on canine leukocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2009.12.006

Measurement and biological correlates of antibody bioactivity during antibody immunotherapies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2009.12.006

Phenotypic and functional characterisation of porcine CD4(+)CD25(high) regulatory T cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2009.12.006

A monoclonal antibody that appears to recognize the receptor for human T-cell growth factor; partial characterization of the receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2009.12.006

Stable antibody-producing murine hybridomas

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2009.12.006

Interleukin-2-receptor blockade with daclizumab to prevent acute rejection in renal transplantation. Daclizumab Triple Therapy Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2009.12.006

10.1016/J.VETIMM.2009.12.006

7 January 2021

Identifiers

DOI

1 reference

29 July 2017

1 reference

29 July 2017

1 reference